BioMark Diagnostics Inc. (BMKDF)
USD 0.15
(0.0%)
USD 0.15
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 163.22 Thousand CAD | 6.34% |
| 2023 | 153.49 Thousand CAD | 249.38% |
| 2022 | 43.93 Thousand CAD | 0.0% |
| 2021 | - CAD | -100.0% |
| 2020 | 263.28 Thousand CAD | 0.0% |
| 2019 | - CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 39.74 Thousand CAD | 0.0% |
| 2024 Q2 | 42.12 Thousand CAD | 5.99% |
| 2024 Q3 | 41.54 Thousand CAD | -1.38% |
| 2024 FY | 163.22 Thousand CAD | 6.34% |
| 2024 Q4 | 39.8 Thousand CAD | -4.18% |
| 2023 Q1 | 35.9 Thousand CAD | 48.87% |
| 2023 Q4 | 39.74 Thousand CAD | 7.74% |
| 2023 Q2 | 40.95 Thousand CAD | 14.09% |
| 2023 Q3 | 36.88 Thousand CAD | -9.93% |
| 2023 FY | 153.49 Thousand CAD | 249.38% |
| 2022 FY | 43.93 Thousand CAD | 0.0% |
| 2022 Q4 | 24.11 Thousand CAD | 21.68% |
| 2022 Q3 | 19.81 Thousand CAD | 0.0% |
| 2022 Q2 | - CAD | 0.0% |
| 2022 Q1 | - CAD | 0.0% |
| 2021 Q4 | - CAD | 0.0% |
| 2021 FY | - CAD | -100.0% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 Q3 | - CAD | 0.0% |
| 2021 Q2 | - CAD | 0.0% |
| 2020 Q1 | - CAD | 0.0% |
| 2020 Q4 | - CAD | -100.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 FY | 263.28 Thousand CAD | 0.0% |
| 2020 Q3 | 263.28 Thousand CAD | 0.0% |
| 2019 Q3 | - CAD | 0.0% |
| 2019 FY | - CAD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 Q2 | - CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 100.0% |
| 2016 Q3 | - CAD | -100.0% |
| 2016 Q2 | 4410.00 CAD | 0.0% |
| 2016 Q1 | - CAD | 100.0% |
| 2016 Q4 | -4410.00 CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 Q3 | 9200.00 CAD | 0.0% |
| 2015 Q4 | -9200.00 CAD | -200.0% |
| 2015 FY | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Bio Medica Corporation | 913 Thousand USD | 82.123% |
| Arrayit Corporation | 4.37 Million USD | 96.271% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 25.85 Million USD | 99.369% |
| Bioqual, Inc. | 58.59 Million USD | 99.721% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 15.29 Million USD | 98.933% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | 99.998% |
| HTG Molecular Diagnostics, Inc. | 6.36 Million USD | 97.436% |
| iMD Companies, Inc. | - USD | -Infinity% |
| IDenta Corp. | 1.05 Million USD | 84.479% |
| Interpace Biosciences, Inc. | 40.21 Million USD | 99.594% |
| Integrative Health Technologies, Inc. | 447.49 Thousand USD | 63.526% |
| InVitro International | 792.62 Thousand USD | 79.408% |
| Lumos Diagnostics Holdings Limited | 11.13 Million USD | 98.534% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 7.22 Million USD | 97.741% |
| NovelStem International Corp. | 12 Thousand USD | -1260.167% |
| Optigenex Inc. | 465.97 Thousand USD | 64.972% |
| PharmChem, Inc. | 6.01 Million USD | 97.285% |
| Proteome Sciences plc | 6.4 Million USD | 97.45% |
| Response Genetics, Inc | 18.04 Million USD | 99.095% |
| Rennova Health, Inc. | 13.03 Million USD | 98.748% |
| RushNet, Inc. | 1.78 Million USD | 90.871% |
| ScreenPro Security Inc. | 1.91 Million USD | 91.473% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 3.79 Million USD | 95.699% |
| Todos Medical Ltd. | 7.69 Million USD | 97.879% |